Inactive Instrument

Other languages Clinigen Group plc

Equities

CLIN

GB00B89J2419

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Clinigen Launches NaviGATE an Educational Programme for Rare Disease Patients and Organizations	23-09-12
CNX Therapeutics Limited acquired Cardioxane® (dexrazoxane), Savene® (dexrazoxane), Totect® (dexrazoxane) and Ethyol®, four cancer support therapies from Clinigen Limited.	23-08-09
Clinigen Limited Reports Earnings Results for the Full Year Ended June 30, 2022	23-05-08
Adragos Pharma GmbH completed the acquisition of Lamda Laboratories S.A. from Clinigen Limited.	23-04-02
Clinigen Group plc acquired Drug Safety Navigator, LLC.	22-12-30
Clinigen Notes Results from the MIROCALS Trial Investigating Low Dose Proleukin® (Aldesleukin) in Patients with Amyotrophic Lateral Sclerosis	22-12-08
Clinigen Expands US Site Capacity in Response to Growing Demand for Clinical Supplies Management Services	22-05-24
Triton Funds Company Completes Takeover Of Clinigen	22-04-04
Triton Fund V SCSP, Triton Fund V L.P., Triton Fund V F&F No. 5 SCSp, Triton Fund V F&F No.3 L.P., Triton Fund V F&F L.P., Triton Fund V F&F No. 2 L.P., Triton Fund V F&F 4 SCSp and Triton C Investment A L.P., managed by Triton completed the acquisition of Clinigen Group plc.	22-04-03
UK's High Court Approves Clinigen's Takeover	22-03-31
Clinigen's Fiscal H1 Profit Sinks As Sales, Administrative Costs Rise	22-02-23
Clinigen Group plc Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-23
Scentre Group CEO/Managing Director to Step Down End-September; Shares Fall 5%	22-02-22
Clinigen Expects to Complete $1.8 Billion Sale to Triton in Early April	22-02-16
Humanigen lanceert managed access program (MAP) voor lenzilumab	22-02-11
Humanigen lance un Programme d’accès géré pour le lenzilumab	22-02-10
Humanigen startet verwaltetes Zugangsprogramm für Lenzilumab	22-02-10
Humanigen lancia il programma di accesso gestito per Lenzilumab	22-02-10
Humanigen lanza un programa de acceso gestionado para lenzilumab	22-02-10
Clinigen Group plc Signs Distribution Agreement with Deciphera Pharmaceuticals	22-02-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Clinigen Group plc

Equities

CLIN

GB00B89J2419

Other languages

Filters